Tudor Investment Corp’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-24,464
Closed -$58.7K 2352
2023
Q4
$58.7K Buy
24,464
+2,081
+9% +$4.89K ﹤0.01% 2264
2023
Q3
$76.1K Buy
+22,383
New +$124K ﹤0.01% 2166
2022
Q2
Sell
-32,557
Closed -$1.34M 2206
2022
Q1
$1.34M Buy
+32,557
New +$1.44M 0.03% 747
2021
Q4
Sell
-35,580
Closed -$1.78M 2561
2021
Q3
$1.78M Buy
35,580
+30,787
+642% +$1.86M 0.03% 793
2021
Q2
$302K Sell
4,793
-4,100
-46% -$263K 0.01% 1340
2021
Q1
$826K Sell
8,893
-7,756
-47% -$794K 0.02% 927
2020
Q4
$1.49M Buy
+16,649
New +$1.53M 0.04% 541
2017
Q2
Sell
-7,000
Closed -$203K 1103
2017
Q1
$203K Sell
7,000
-2,700
-28% -$82.2K 0.01% 1217
2016
Q4
$319K Buy
+9,700
New +$291K 0.01% 986
2016
Q3
Sell
-16,200
Closed -$456K 1495
2016
Q2
$456K Sell
16,200
-8,432
-34% -$331K 0.01% 902
2016
Q1
$895K Sell
24,632
-2,164
-8% -$76.4K 0.02% 577
2015
Q4
$1.07M Sell
26,796
-5,570
-17% -$194K 0.03% 415
2015
Q3
$922K Buy
32,366
+17,066
+112% +$562K 0.03% 419
2015
Q2
$504K Buy
15,300
+2,608
+21% +$80.9K 0.01% 774
2015
Q1
$365K Buy
12,692
+5,192
+69% +$149K 0.01% 927
2014
Q4
$204K Sell
7,500
-16,500
-69% -$393K 0.01% 1267
2014
Q3
$511K Sell
24,000
-5,400
-18% -$124K 0.02% 658
2014
Q2
$660K Buy
29,400
+8,657
+42% +$202K 0.03% 387
2014
Q1
$524K Buy
+20,743
New +$524K 0.02% 496
2013
Q3
Sell
-21,900
Closed -$316K 841
2013
Q2
$316K Buy
+21,900
New +$317K 0.02% 528

Other funds holding EBS